ECHELON BIOSCIENCES, INC.

Company Information
Address 675 Arapeen Drive, Suite 302
Salt Lake City, UT, 84108-1228


Information

DUNS: 179151188

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. IGF OT IGF BIOMARKERS FOR ALCOHOL AND ALD

    Amount: $29,261.00

    This contract addresses the need for reliable and accurate biomarkers of alcohol consumption initially in response to a National Institute on Alcohol Abuse and Alcoholism NIAAA initiated Small Busi ...

    SBIRPhase II2015Department of Health and Human Services
  2. Targeting ether lipid biosynthesis for disease

    Amount: $224,334.00

    DESCRIPTION (provided by applicant): Cancer is a significant health burden in the US and across the globe, representing the second leading cause of death in the US. Cancer cells have metabolic pathway ...

    SBIRPhase I2014Department of Health and Human Services
  3. IGF::OT::IGF-- Biomarkers for Alcohol and ALD

    Amount: $625,360.00

    This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Busi ...

    SBIRPhase II2014Department of Health and Human Services
  4. New Approach to Phospholipidosis Prediction

    Amount: $875,580.00

    DESCRIPTION provided by applicant Drug safety is a major concern for pharmaceutical groups regulatory bodies basic researchers and particularly patients Safe and effective drugs maximize success ...

    SBIRPhase II2014Department of Health and Human Services
  5. SBIR Phase II: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

    Amount: $487,812.00

    This Small Business Innovation Research (SBIR) Phase II project aims to further develop ATX-Red, an in vivo imaging agent that becomes fluorescent in the presence of the enzyme autotaxin. Autotaxin an ...

    SBIRPhase II2012National Science Foundation
  6. SBIR PHASE II- 1,136,508YR 1: BASE: 548,090, PARTIALLY FUNDED AT 430,000 (BALANCE TO BE FUNDED: 118,090)YR 2: OPTION: 588,418

    Amount: $548,090.00

    There needs to better biomarkers of alcohol consumption and alcohol induced organ damage. PEth is a nonoxidative, long-lasting metabolite of ethanol consumption and alcohol related organ damage. PEth ...

    SBIRPhase II2012Department of Health and Human Services
  7. New Approach to Phospholipidosis Prediction

    Amount: $149,884.00

    DESCRIPTION (provided by applicant): Drug safety is a major concern for people that taking medicines as well as pharmaceutical companies, regulatory bodies, and basic researchers. Drug induced phospho ...

    SBIRPhase I2011Department of Health and Human Services
  8. SBIR Phase I: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project aims to synthesize ATXRed, an in vivo imaging agent that is specifically activated by the enzymatic activity of autotaxin. Autotaxin is a ...

    SBIRPhase I2010National Science Foundation
  9. Anti-Phospholipid Multiplex For Pathologic Epitopes

    Amount: $248,864.00

    DESCRIPTION (provided by applicant): This project will help delineate the true nature of antigens in antiphospholipid syndrome (APS). Application of this knowledge would accelerate the pace of basic a ...

    SBIRPhase I2010Department of Health and Human Services
  10. Aptamer-based Glycomics Tools

    Amount: $277,549.00

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. ...

    STTRPhase II2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government